Germline and somatic genetic drivers of adrenocortical tumours.

Primary Hyperaldosteronism: Epidemiology, Diagnosis, and Clinical Associations.

Description of the novel variant c.784delG;p. (Ala262Profs*68) at BSND gene and its association with Bartter Syndrome Type Iva.

Clinical implications of aldosterone responsiveness to adrenocorticotropic hormone stimulation in two major subtypes of primary aldosteronism.

Early-onset hypertension associated with a CACNA1H variant of uncertain significance: a case report and literature review.

Pathogenesis of primary aldosteronism.

Diagnosis of primary aldosteronism: Renin activity, renin concentration and aldosterone/renin ratio.

Adrenal histologic and genetic characteristics of primary aldosteronism in late adulthood.

The adrenal gland and primary aldosteronism: anatomy, steroidogenesis, regulation, and genetic insights.

New mutation of CACNA1H p.Tyr613Phe in hyperaldosteronism: a case report.

Rho/ROCK signaling and α-catenin mediate β-catenin-driven hyperplasia in the adrenal cortex via adherens junctions.

[Endocrinology : what's new in 2025].

Regulation of Aldosterone Secretion by Substance P and the Neurokinin Type 1 Receptor in Aldosterone-Producing Adenomas.

A novel 2D and 3D model for primary adrenocortical carcinoma of advanced and metastasized stage co-secreting cortisol, aldosterone, testosterone, 18-oxocortisol and 18-hydroxycortisol.

Papillary thyroid carcinoma and primary aldosteronism: A new syndrome or a mere association?

When teeth and kidneys fail together: a case series of amelogenesis imperfecta-renal syndromes in childhood.

FOS and JUN regulate oxidative stress and steroidogenesis in human aldosterone-producing adenomas.

GWAS and Replication Analysis of Apparent Treatment-Resistant Hypertension.

Recurrent CACNA1HE282K is a gain-of-function mutation associated with primary hyperaldosteronism.

Type 1 Bartter syndrome presenting as primary diabetes insipidus: a rare Case Report with 8-year follow-up.

Refractory hypercalcemic crisis: A case of primary hyperparathyroidism with Gitelman syndrome.

Subclinical primary aldosteronism.

Regulation of Klotho Production by Mineralocorticoid Receptor Signaling in Renal Cell Lines.

Exploring Etiologies of Hypokalemic Paralysis: A Case Series.

Acid-sensing ion channel 1a deficiency drives endocrine hypertension in male mice.

Primary aldosteronism complicated by early-onset heart failure in a young male with a coexisting DMD variant: A case report and literature review.

Molecular investigation of primary aldosteronism: exploring genetic heterogeneity in understudied populations.

Osmolarity Controls Oscillatory Calcium Signaling to Reduce Autonomous Aldosterone Production in Zona Glomerulosa Cells.

Novel Compound Heterozygous Mutation in the KCNJ1 Gene Causes Bartter Syndrome.

Adipose tissue signaling in aldosterone-producing adenomas: paracrine and endocrine effects.

Glucocorticoid Remediable Aldosteronism in a Family with a Strong History of Cerebral Aneurysms and Hypertension.

[The relationship between surgical outcomes and KCNJ5 mutations and pathological classification in patients with unilateral primary aldosteronism].

[Analysis of a family with familial hyperaldosteronism type Ⅳ due to a mutation in the CACNA1H gene].

Histopathological features of aldosterone-producing lesions according to their different somatic genetic mutations.

Somatic Mutations in MCOLN3 Are Associated With Aldosterone-Producing Adenomas.

An interesting case of coexistence of autosomal dominant hypocalcemia 1 with Bartter syndrome and chronic myelogenous leukemia.

Perirenal Adipose Tissue and Hypertension: Observational and Genetic Analyses.

Prolonged hypokalemia long after causative factor elimination in pseudo-Bartter/Gitelman syndrome.

[A case of extremely premature infant with type Ⅱ Bartter syndrome characterized by hyperkalemia].

The Significance of High Expression of Circulating miR-222-3p in Patients With Unilateral Primary Aldosteronism.

Amnioreduction as a therapeutic strategy for MAGED2 -related Bartter syndrome: prolonging gestation and improving outcomes through genetic-guided prenatal management.

Case Report: Type II Bartter syndrome with a novel KCNJ1 variant in a premature neonate presenting with features of salt-wasting congenital adrenal crisis and pseudo-hypoaldosteronism.

Generation of a Bartter syndrome type 3 patient-derived induced pluripotent stem cell line ISRM-BS3-UM18-iPSC (HHUUKDi014-A).

Ultra-rare severe kidney dysplasia mimicking salt-wasting tubulopathy associated with TFCP2L1 gene variants.

Improved and individualized approach to adrenal surgery.

Adrenal causes of endocrine hypertension in childhood or adolescence.

Searching for peripheral proteomic markers of primary aldosteronism.

Proteomic signatures to detect unilateral primary aldosteronism in hypertensive patients.

Connecting the dots: renin-angiotensin-aldosterone system, vitamin D, and hypertension.

Intronic variants impacting SLC12A1 gene splicing in Bartter syndrome type 1: Characterization of a novel deep intronic variant via Whole-genome sequencing and minigene analysis.

Intercalated Cell ClC-K2 Channel Contributes to Systemic Cl- Balance and Acid-Base Homeostasis.

Early reduction of skin potassium without sodium accumulation in the pathogenesis of salt sensitivity in primary aldosteronism.

ABCC3 Is a Differential Marker of CYP11B2-Negative Zona Glomerulosa Cells in Human Adrenal Cortex.

Beclin-1-dependent autophagy protects perivascular adipose tissue function from hyperaldosteronism effects.

Advances in the biochemical diagnostics of primary aldosteronism: from immunoassays to steroidomics and proteomics.

Prevalence of KCNJ5 mutations in aldosterone-producing adenomas among Malaysian primary aldosteronism patients: Genotype-phenotype correlation.

Association between ARMC5 mutation with bilateral macronodular adrenal hyperplasia and primary aldosteronism: A case report.

Serum microRNAs as peripheral markers of primary aldosteronism.

Fetal umbilical vein thrombosis associated with fetal bartter syndrome: an unusual case report and literature review.

Causal association between genetically predicted primary aldosteronism and aortic aneurysm and aortic dissection: A Mendelian randomization study.

Hypocalcemic Tetany Transiently "Cured" by Pregnancy: A Case Report.

Identification of hypertension subtypes using microRNA profiles and machine learning.

MicroRNA-24-3p targeting Top1 in perirenal fat is involved in circulating inflammation and high cardiovascular disease risk in patients with primary aldosteronism.

Rare Case of Adult-Onset Gitelman Syndrome in a Patient With Multiple Comorbidities: A Case Report.

Plasmacytoid Dendritic Cell Content Is Associated With Plasma Aldosterone Concentration in Patients With Primary Aldosteronism.

Evaluation of Aldosterone Suppression by Cinnarizine, a Putative Cav1.3 Inhibitor.

Multiomics reveal key inflammatory drivers of severe obesity: IL4R, LILRA5, and OSM.

Multiomics analysis unveils the cellular ecosystem with clinical relevance in aldosterone-producing adenomas with KCNJ5 mutations.

Unilateral Primary Aldosteronism Lacking KCNJ5 Somatic Mutations Is Associated With an Elevated Risk of New-Onset Diabetes.

Bartter syndrome as natural experiment if furosemide (re)opens the ductus arteriosus.

Modulation of Calcium Signaling on Demand to Decipher the Molecular Mechanisms of Primary Aldosteronism.

An early onset Gitelman syndrome presenting in a boy with failure to thrive with recurrent hypokalemia and hypomagnesemia: a case report.

Shifting paradigms in primary aldosteronism: reconsideration of screening strategy via integrating pathophysiological insights.

Neonatal pseudo-hypoaldosteronism type 1 with a novel NR3C2 gene variant.

Clinical Utility of Dual-Time 68Ga-Pentixafor PET/CT in Diagnosing and Subtyping Primary Aldosteronism.

EGR1 regulates oxidative stress and aldosterone production in adrenal cells and aldosterone-producing adenomas.

Decoding Monogenic Hypertension: A Review of Rare Hypertension Disorders.

Integrative bioinformatics approach identifies novel drug targets for hyperaldosteronism, with a focus on SHMT1 as a promising therapeutic candidate.

KCNJ5 Somatic Mutations Are Associated With Better Long-term Outcomes in Patients With Unilateral Primary Aldosteronism.

Renin-independent aldosteronism and metabolic dysfunction-associated steatotic liver disease and cirrhosis: A genetic association study.

ATP2A3 in Primary Aldosteronism: Machine Learning-Based Discovery and Functional Validation.

Clinical comparison and genetic analysis in pheochromocytoma with primary aldosteronism.

Chronological outcomes of renal function after adrenalectomy in patients with primary aldosteronism across age groups.

Attenuation of Hypertension and protection of vascular inflammation in hyperaldosteronism: GPER1 as potential therapeutic candidate when MR antagonist is less satisfying?

Influence of smoking on cardiometabolic profile and surgical outcomes in patients with primary aldosteronism: a cohort study.

Targeted multiplex proteomics for the development and validation of biomarkers in primary aldosteronism subtyping.

Comparative Analysis of Liquid Chromatography-Tandem Mass Spectrometry and Radioimmunoassay in Determining Plasma Aldosterone Concentration and Plasma Renin Activity for Primary Aldosteronism Screening.

Evolutionary Characteristics in Primary Aldosteronism Patients.

Finerenone as a Novel Treatment for Gitelman Syndrome: A Case Study of a 35-Year-Old Male with Adrenal Mass and Hypokalemia.

Pseudo-Bartter syndrome: A CFTR-related disorder?

Persistent renal dysfunction post-chemotherapy: a diagnostic conundrum in pediatric cancer survivorship - a case report.

Aldosterone-induced salt appetite requires HSD2 neurons.

Cardiovascular and arrhythmic manifestations of Bartter's and Gitelman's syndromes: do not forget the heart. A narrative literature review.

Two-hit model for the development of aldosterone-producing adenoma: supporting from two new cases.

Somatic GNAQ, CTNNB1, and CACNA1C Mutations in Cat Aldosterone-Secreting Tumors.

Circulating miRNAs and Machine Learning for Lateralizing Primary Aldosteronism.

ClC-Kb pore mutation disrupts glycosylation and triggers distal tubular remodeling.

Immunohistochemical expression of CYP11A1, CYP11B, CYP17, and HSD3B2 in functional and nonfunctional canine adrenocortical tumors.

Clinical Features and Unusual Heterozygous Mutations in Patients with Renal Hypokalemia.

Primary Aldosteronism Influences Cardiac Structure, Function, and Disease Risk: Evidence From Mendelian Randomization Analysis.

Water and Electrolyte Content in Hypertension in the Skin (WHYSKI) in Primary Aldosteronism.

Screening and treatment of endocrine hypertension focusing on adrenal gland disorders: a narrative review.

An Unusual Case of Myoglobin Cast Nephropathy in a Patient with Bartter Syndrome: A Rare Entity.

Untangling the Uncertain Role of Overactivation of the Renin-Angiotensin-Aldosterone System with the Aging Process Based on Sodium Wasting Human Models.

SLC12A1 variant c.1684+1 G>A causes Bartter syndrome type 1 by promoting exon 13 skipping.

Exploring the pathogenesis linking primary aldosteronism and obstructive sleep apnea via bioinformatic analysis.

Genetic testing for familial hyperaldosteronism type 1 in Aotearoa/New Zealand.

A New Case Report of a CLCNKB Complex Heterozygous Mutation in Adult-Onset Type III Bartter Syndrome.

[Two cases of Dent disease type 1 with Bartter-like phenotype and literature review].

[Research progress of KCNJ5 gene in aldosterone-producing adenoma].

A missense variant in SLC12A3 gene enhances aberrant splicing causing Gitelman syndrome.

Primary Aldosteronism and Hypokalemia-induced Rhabdomyolysis in a Patient with Aldosterone-producing Adenoma: A Case Report and Literature Review.

Unveiling the Causal Relationship of Cardiovascular Burden in Primary Aldosteronism by Genome-Wide Association and Mendelian Randomization: A Possible Solution?

Primary Aldosteronism and Risk of Cardiovascular Outcomes: Genome-Wide Association and Mendelian Randomization Study.

Genetic Testing for Primary Aldosteronism in SPAIN: Results From the SPAIN-ALDO Registry and Review of the Literature.

Case report: Two novel compound heterozygous variant of SLC12A3 gene in a gitelman syndrome family and literature review.

Impact of primary aldosteronism on kidney function: results from the SPAIN-ALDO registry.

X-linked transient antenatal Bartter syndrome related to MAGED2 gene: Enriching the phenotypic description and pathophysiologic investigation.

Rare correlation of somatic PRKACA mutations with pregnancy-associated aldosterone- and cortisol-producing adenomas: a case report and literature review.

Paradoxes in magnesium transport in type 1 Bartter's syndrome and Gitelman's syndrome: a modeling analysis.

[Two Cases of Pseudo-Bartter Syndrome in Childhood: When to Suspect a Rare Onset Pattern of Cystic Fibrosis].

Macrophages preserve endothelial cell specialization in the adrenal gland to modulate aldosterone secretion and blood pressure.

Postnatal renal tubule development: roles of tubular flow and flux.

Double CYP11B1/CYP11B2 Immunohistochemistry and Detection of KCNJ5 Mutations in Primary Aldosteronism.

Bartter Syndrome Presenting as Arginine-Vasopressin Resistance: A Report of 2 Cases.

Monogenic Hypertension Linked to the Renin-Angiotensin-Aldosterone System.

Report on three cases of familial primary aldosteronism type IV.

[Cystic fibrosis primarily presenting with pseudo-Bartter syndrome: a report of three cases and literature review].

Protein Quality Control of NKCC2 in Bartter Syndrome and Blood Pressure Regulation.

KCNJ5 mutations in familial and non-familial primary aldosteronism.

The influence of cortisol co-secretion on clinical characteristics and postoperative outcomes in unilateral primary aldosteronism.

Polymyxin B-induced Bartter syndrome.

The association between blood pressure variability and renal damage in patients with primary aldosteronism.

Cardiovascular Outcomes of KCNJ5 Mutated Aldosterone-Producing Adenoma: A Systematic Review.

Review of childhood genetic nephrolithiasis and nephrocalcinosis.

17α-hydroxylase/17,20-lyase Deficiency Diagnosed at 45 Years of Age with Hyperaldosteronism.

Zona Glomerulosa-Derived Klotho Modulates Aldosterone Synthase Expression in Young Female Mice.

Familial hyperaldosteronism: an European Reference Network on Rare Endocrine Conditions clinical practice guideline.

Adult classic Bartter syndrome: a case report with 5-year follow-up and literature review.

Practical consensus for the treatment and follow-up of primary aldosteronism: a multidisciplinary consensus document.

Double somatic mutations in CTNNB1 and GNA11 in an aldosterone-producing adenoma.

Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism.

AUP1 Regulates the Endoplasmic Reticulum-Associated Degradation and Polyubiquitination of NKCC2.

Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism.

MicroRNAs in aldosterone production and action.

Bartter syndrome-like phenotype in a patient with type 2 diabetes mellitus.

Chronic activation of adrenal Gq signaling induces Cyp11b2 expression in the zona fasciculata and hyperaldosteronism.

Unilateral Primary Aldosteronism: Long-Term Disease Recurrence After Adrenalectomy.

A case of pseudo-Bartter/Gitelman syndrome caused by long-term laxative abuse, leading to end-stage kidney disease.

Pseudo-Bartter syndrome as the initial presentation of cystic fibrosis in children: an important diagnosis not to be missed.

Identification of a novel intronic mutation of MAGED2 gene in a Chinese family with antenatal Bartter syndrome.

Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry.

No extra-adrenal aldosterone production in various human cell lines.

Multifocal, Asymmetric Bilateral Primary Aldosteronism Cannot be Excluded by Strong Adrenal Vein Sampling Lateralization: An International Retrospective Cohort Study.

Successful antenatal treatment of MAGED2-related Bartter syndrome and review of treatment options and efficacy.

Clinical analysis of salt-wasting in infants due to genetic aetiology.

Epigenetic alterations of 11beta-hydroxysteroid dehydrogenase 1 gene in the adipose tissue of patients with primary aldosteronism.

Cross-Disciplinary Approach of Adrenal Tumors: Insights into Primary Aldosteronism-Related Mineral Metabolism Status and Osteoporotic Fracture Risk.

Primary aldosteronism and lower-extremity arterial disease: a two-sample Mendelian randomization study.

Water and Electrolyte Content in Salt-Dependent HYpertension in the SKIn (WHYSKI): Effect of Surgical Cure of Primary Aldosteronism.

Bartter Syndrome Unveiled: Unraveling the Masquerade of Neuroregression.

Urine steroid metabolomics as a diagnostic tool in primary aldosteronism.

The predictors of long-term outcomes after targeted therapy for primary Aldosteronism.

Single-Nucleus Analysis Reveals Tumor Heterogeneity of Aldosterone-Producing Adenoma.

Long-Term Indomethacin Treatment in a Chinese Child with Gitelman Syndrome: Case Report and Literature Review on its Efficacy and Tolerance.

Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss.

Recurrent transient severe hypocalcaemia in two siblings with type 1 Bartter syndrome.

[Mechanism of miR-186-5p Regulating PRKAA2 to Promote Ferroptosis 
in Lung Adenocarcinoma Cells].

Liddle syndrome presenting with normal aldosterone levels: A case report.

Is adrenal venous sampling always necessary to differentiate between unilateral and bilateral primary aldosteronism? Lesson from the SPAIN-ALDO register.

Rewriting DNA in the body lowers cholesterol.

Genome mining yields putative disease-associated ROMK variants with distinct defects.

Therapeutic management of congenital forms of endocrine hypertension.

CACNA1D Gene Polymorphisms Associate With Increased Blood Pressure and Salt Sensitivity of Blood Pressure in White Individuals.

Uncommon Presentation of Cystic Fibrosis: A Case Report and Literature Review.

Clinical Research on Rett Syndrome: Central Hypoxemia and Hypokalemic Metabolic Alkalosis.

Pathology and gene mutations of aldosterone-producing lesions.

Bartter Syndrome: A Systematic Review of Case Reports and Case Series.

Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism.

Mechanism of DYRK1a in myocardial ischemia-reperfusion injury by regulating ferroptosis of cardiomyocytes.

Isradipine therapy in Cacna1dIle772Met/+ mice ameliorates primary aldosteronism and neurologic abnormalities.

Emerging association between KCNJ5 mutations and vascular failure in primary aldosteronism.

Pattern of hereditary renal tubular disorders in Egyptian children.

ATP1A1-linked diseases require a malfunctioning protein product from one allele.

Long-read sequencing identifies a common transposition haplotype predisposing for CLCNKB deletions.

Primary aldosteronism: molecular medicine meets public health.

A novel homozygous CLCNKB variant: An early presentation of classic Bartter syndrome in a neonate.

Genotypic variability in patients with clinical diagnosis of Bartter syndrome type 3.

Clinical Findings and Genetic Analysis of Nine Mexican Families with Bartter Syndrome.

Adrenal Anion Channels: New Roles in Zona Glomerulosa Physiology and in the Pathophysiology of Primary Aldosteronism.

KCNJ5 mutation is a predictor for recovery of endothelial function after adrenalectomy in patients with aldosterone-producing adenoma.

Decaying kidney function during cirrhosis correlates with remodeling of distal colon aldosterone target gene expression.

Relevance of KCNJ5 in Pathologies of Heart Disease.

Effect of Obesity on Clinical Characteristics of Primary Aldosteronism Patients at Diagnosis and Postsurgical Response.

CaV3.2 (CACNA1H) in Primary Aldosteronism.

Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production.

A Novel Enzymatic Hydrolysis Method for Urine Aldosterone Quantification: A Case for Reassessing Clinical Cut-Offs of Primary Aldosteronism.

Gitelman Syndrome: A Case Report.

Renin-independent aldosteronism and chronic kidney disease in diabetes: Observational and Mendelian randomization analyses.